64 results
8-K
EX-99.1
INO
Inovio Pharmaceuticals Inc
9 Nov 23
INOVIO Reports Third Quarter 2023 Financial Results
4:15pm
engagement and reimbursement, specialty pharmacy identification, patient and provider awareness and education, customer service programs, and other
8-K
EX-99.1
INO
Inovio Pharmaceuticals Inc
10 May 23
INOVIO Reports First Quarter 2023
4:20pm
a noteworthy engagement of T cells, including increased production of IFNg, IL2, and/or TNFa from EBOV-specific CD4+ and CD8+ T cells. The additional data